Technology-based intervention for young adults with HIV
iVY: Comprehensive, Tailored, Technology-based Intervention to Improve Virologic Suppression Among Youth and Young Adults Living With HIV
This study tests a new program that uses video counseling and a mobile app to help young adults with HIV get better care and support for their health and well-being.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 200 (estimated) |
| Ages | 18 Years to 29 Years |
| Sex | All |
| Sponsor | University of California, San Francisco Academic / other |
| Locations | 1 site (San Francisco, California) |
| Trial ID | NCT05877729 on ClinicalTrials.gov |
What this trial studies
This clinical trial tests a technology-based intervention combining video counseling and a mobile health app for young adults aged 18-29 living with HIV. Participants who are not virologically suppressed will be randomized to receive either the intervention or standard care. The intervention aims to address barriers to HIV care, mental health, and substance use through tailored support and resources. The study employs an Adaptive Treatment Strategy to customize care based on individual needs, with the goal of improving virologic suppression rates.
Who should consider this trial
Good fit: Ideal candidates are young adults aged 18-29 who are HIV positive and live in California.
Not a fit: Patients who are unable to provide consent or have severe cognitive impairments may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve HIV treatment outcomes and mental health for young adults living with HIV.
How similar studies have performed: Other studies have shown promise in using technology-based interventions for HIV care, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. 18-29 years of age 2. HIV seropositive 3. Live and receive HIV care in California 4. HIV VL test result of \>20 copies at some point in the last 12 months 5. Able to speak English 6. Have access to smartphone Exclusion Criteria: 1. Unable or unwilling to provide consent. 2. Evidence of severe cognitive impairment, active psychosis, or substance use that may impede ability to provide informed consent during the consent process. 3. Those with a history of hemophilia or unable to conduct finger prick at home for the HIV viral load testing.
Where this trial is running
San Francisco, California
- Division of Prevention Science, Center for AIDS Prevention Studies (CAPS) — San Francisco, California, United States (Recruiting)
Study contacts
- Principal investigator: Parya Sabari, PharmD — UCSF School of Medicine, Division of Prevention Science
- Study coordinator: Kristin Ming
- Email: ivy@ucsf.edu
- Phone: 415-735-1507
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.